CLX – The Clorox Company

Clorox Company Monthly Stock Report – November 28, 2025

Company Overview

The Clorox Company, headquartered in Oakland, California, has been a stalwart in the Household & Personal Products industry since its founding in 1913. Known for its diverse portfolio, Clorox operates across four key segments: Health and Wellness, Household, Lifestyle, and International. Its offerings encompass a wide range of consumer and professional products, including cleaning and disinfecting agents, cat litter, bags and wraps, and personal care items. The company serves multiple distribution channels, notably mass retailers, grocery outlets, and e-commerce platforms. Positioned within the Consumer Defensive sector, Clorox maintains solid market presence, although current analyst recommendations suggest a cautious “hold” rating on its stock, indicating a wait-and-see approach for potential investors.

52-Week Price Performance Analysis

Analyzing Clorox’s 52-week price performance indicates a notable bearish trend. The stock began its downward trajectory from a high of $171.37, recently dropping to a current price of $107.75–a significant decline of approximately 33.13%. This downturn is characterized by consistent lower highs and lower lows as shown in the downward-sloping green trend line on the stock chart.

Key technical insights suggest:
– Resistance Levels: The $160 level, where Clorox peaked in November, serves as a major resistance point. Any attempts to return to this level have consistently failed, indicating substantial bearish sentiment.
– Support Levels: The current stock price of $107.75 is identified as immediate support. A breach below this mark could signal further downside, prompting potential investors to monitor closely.
– Moving Average: The fifty-day moving average is positioned at $114.19, further suggesting bearish conditions since the stock trades below this line. With continued trading below both the moving average and the trend line, the absence of bullish reversal patterns keeps the downward trajectory intact.

Overall, without a significant catalyst for reversal, investors may need to exhibit caution and monitor for possible stabilization signals before contemplating new long positions.

Financial Performance and Metrics

Clorox’s financial performance data reveals several key indicators worth noting:
– Total Revenue: Clorox reported total revenue of approximately $6.77 billion, reflecting its strong operational standing despite recent market challenges.
– Profitability: The company boasts an impressive adjusted EBITDA of around $1.22 billion, ensuring healthy operational performance and profitability, thus reinforcing cautious optimism for long-term investors.
– Valuation Metrics: The asset price currently stands at $107.75, with a target high set at $163.00, signalling a substantial growth opportunity. The mean price target across analysts is approximately $124.59, suggesting the stock has room for appreciation, albeit within a watchful context.

Financial Health Indicators

• Shares Outstanding: Clorox has 121,980,379 shares outstanding, with 6,743,777 shares held short–equating to around 6.36% of the company’s float. This relatively low short interest implies that while bearish sentiment exists, the majority of investors maintain a more optimistic outlook.

The projected earnings per share have also seen positive adjustments, with an anticipated range of $6.65 to $6.90, reflecting an 8-12% increase year-over-year, enhancing the case for future recovery.

Recent News and Developments

In recent months leading up to November 2025, several developments have notably influenced Clorox’s market performance:
– 52-Week Low: In October 2025, Clorox’s stock reached its 52-week low of $116.48, showcasing a 26.58% decline year-over-year. This deterioration was primarily attributed to weakened consumer demand amid economic uncertainties and the lingering effects of a significant cyberattack in August 2023, which disrupted operations.
– Strategic Initiatives: In response to these challenges, Clorox has executed strategic measures, including price adjustments and cost-saving initiatives, aimed at bolstering its financial standing. These efforts have yielded favorable outcomes, such as a 27% year-over-year increase in net sales during the first quarter of fiscal year 2025, driven by higher volumes and pricing strategies.

Analyst Adjustments

Despite positive sales figures, analyst sentiment conveys caution. Renowned firms like Citigroup and JPMorgan Chase & Co. have recently revised their price targets downwards to $130.00 and $127.00 respectively. These adjustments reflect ongoing concerns surrounding Clorox’s capacity to navigate persistent market challenges and maintain sustainable growth.

Market Sentiment and Analyst Recommendations

The consensus among analysts currently stands at a “hold” recommendation, reflecting cautious sentiment towards Clorox’s stock. With a mean recommendation score of 3.11 derived from 17 analyst opinions, it presents a viewpoint that, while Clorox possesses several opportunities for growth, investors are advised to maintain their current positions rather than making major changes at this time.

Price Target Insights

The analysis of target prices reveals a high estimate of $163.00 juxtaposed with a low estimate of $103.00, indicating a reasonable spectrum of potential gains while stressing the need for careful consideration of market and operational trends. The median target price is notably set at $120.00, aligning closely with the mean.

In summary, Clorox presents a blended investment narrative–showing promise through its robust revenue generation and strategic initiatives, yet tempered by recent price volatility and analyst skepticism. The current price of $107.75 positions it attractively within a volatile market landscape, presenting both opportunities and risks for investors discerning the right time to engage.

Investors are encouraged to continuously monitor Clorox’s operational developments and market sentiment as they navigate their investment decisions.

Metric	Value
Market Cap	$13.1b
Total Debt	$3.1b
Total Cash	$166.0m
Shares Outstanding	122.0m
Float Shares	121.6m